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Abstract
Background: recD, located between recB and argA, encodes the smallest polypeptide (60 kDa) of
the heterotrimeric enzyme RecBCD in Escherichia coli. RecD is a 5'-3' helicase and is required for
the nuclease activity of RecBCD and for tight binding to dsDNA ends. Here, we have tested the
hypothesis that RecD regulates the structure and activities of RecBCD, including RecA loading.
Results: To characterize its regulatory functions, recD was genetically fused to recB through
deletion and substitution mutations. The recB-recD fusion led to a decreased amount of the
heterotrimer. Both fusion mutants proved to be recombination proficient, viable and resistant to
DNA damaging agents, and to have DNA unwinding, ATP-dependent dsDNA exonuclease and Chi
genetic activities.
Conclusion: Our findings suggest that the recB-recD fusion may form a RecBD fusion protein and
therefore affect RecD assembly, but this does not change the three-dimensional structure of the
heterotrimer.
Background
RecBCD is the key enzyme of double strand (ds) breaks
repair and recombination in Escherichia coli [1-3].
RecBCD enzyme is a large heterotrimer (330 kDa) com-
prising RecB, RecC and RecD polypeptides [4,5], and has
dsDNA and single strand (ss)DNA exonuclease, ssDNA
endonuclease, helicase, DNA-dependent ATPase and
RecA loading activities [1-3,6]. This multifunctionality
enables the enzyme to initiate homologous recombina-
tion. RecBCD carries out the presynaptic step of recombi-
nation to produce a 3' single-strand overhang. The E. coli
hotspot Chi (5' GCTGGTGG 3') stimulates recombination
near to and distant from its 3' end, so it facilitates the
enzyme's task [6,7].
Genetic and physical assays show that recombinational
DNA repair in E. coli occurs as follows: if there is a ds
break in the chromosome, RecBCD specifically binds to
the blunt or near-blunt dsDNA ends [8,9]. Unlike other
helicases, RecBCD has two independent helicase subunits,
RecB and RecD, so the enzyme is a processive helicase
(>30 kb) and begins to unwind the dsDNA [10,11]. Ini-
tially the enzyme degrades from the 3'-ended strand until
it reaches the Chi sequence in excess Mg+2 ions. Thereafter,
it degrades the complementary strand as unwinding con-
tinues [12]. The combined helicase and nuclease effects
produce a 3' overhang [12-14]. RecBCD loads the strand-
exchange protein, RecA, on to this 3' overhang to form a
RecA-ssDNA filament. This filament catalyzes the forma-
tion of a D-loop with a homologous dsDNA, which devel-
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ops a Holliday junction structure. Postsynaptic resolution
produces recombinants [15].
A key aspect of this process is the interaction between Chi
and RecBCD, which regulates the structure and activities
of the enzyme. Chi is a recombinational hotspot in the
RecBCD pathway and stimulates recombination up to 30-
fold [16,17]. During unwinding, this octameric sequence
is recognized by the RecC subunit of the enzyme [18-20],
if RecBCD only approaches from the right side [8], and
Chi and enzyme then interact [21]. The enzyme continues
to unwind after Chi, though more slowly [22], and at the
end of the DNA the subunits disassemble to form an inac-
tive enzyme [23]. During the continued unwinding, the
nuclease activity of the enzyme degrades the 5'-end strand
[12], and the enzyme begins to load RecA on to the 3'-end
strand to the left of Chi [24]. The mechanisms of this reg-
ulation are not yet well understood, but it has been sug-
gested that RecD plays a role [25]. On the basis of
similarities between the features of RecBCD lacking RecD
and RecBCD interacting with Chi, the following hypothe-
sis has been proposed: RecD is ejected at Chi to form a
recombinogenic enzyme [26,27]. However, subsequent
studies have shown that purified RecBC is different from
the enzyme interacting with Chi: RecBC lacks exonuclease
and Chi recognition activities, but can load RecA constitu-
tively [20,28,29]. Recent single-molecule studies have
indicated that RecD remains associated with the RecBC
subunits at the Chi site [30,31]. On the other hand, RecD
inhibits RecA loading activity before the Chi site; a point
mutation in the RecA loading domain of RecB eliminates
RecA loading activity, but removing RecD from these
mutants reverses this inactivation [32,33]. Against the
hypothesis that RecD is eliminated at the Chi site, we pro-
pose that RecD is required to regulate RecA loading activ-
ity. To test this proposal, we generated two recB-recD
genetic fusions that would allow us to examine the regu-
latory functions of RecD. We tested four predictions: [1]
the fusion enzymes cannot bind specifically to dsDNA
ends and lack all enzyme activities; [2] the fusion enzymes
can bind to the ends but cannot unwind the dsDNA; [3]
the fusion enzymes can bind and unwind dsDNA, but
lack nuclease and Chi genetic activities; [4] the fusion
enzymes behave like wild type.
In this study we describe the recB-recD fusion mutants that
have wild type phenotypes. Both fusion enzymes are
recombination proficient, can repair DNA damage, and
have DNA unwinding, exonuclease and Chi genetic activ-
ities. However, the fusion between recD and recB reduced
the heterotrimer level. Our findings suggest that recB-recD
fusion may form RecBD, a fusion protein, and may there-
fore affect assembly, but this effect does not change the
three-dimensional structure of the heterotrimer.
Results
recB-recD fusions were generated by recombineering
RecBCD is composed of the products of recB, recC and
recD, which lie between the argA and thyA intergenic
regions of E. coli (Figure 1a). ptr, which encodes protease
III, is located between recC and recB. The recB termina-
tion codon overlaps the initiation codon of the down-
stream recD by one nucleotide. Therefore, recB and recD
form an operon with a major external promoter for both
genes and with a minor internal promoter for recD. The
major promoter to the left of recB directs the transcrip-
tion of the 3543 and 1824 nucleotides of the recB and
recD coding sequences, respectively, whereas the weaker
promoter to the left of recD appears to direct the tran-
scription of recD alone. To generate a genetic fusion
between recB and recD, the mutations were targeted to
this overlap site. Two fusion forms were generated: [1] a
deletion fusion mutation and [2] a substitution fusion
mutation. For the former, two nucleotides (TA) of the
recB termination codon at the overlap site were deleted;
this removes the termination codon of recB but does not
yield a frameshift mutation. For the latter, three codons
encoding two asparagine and one glycine residues,
which has the potential of forming equivalent hydrogen
bonds and facilitates a beta turn respectively, were sub-
stituted at the same site. This substitution leads to a short
bridge between recB and recD.
Recombineering is the name given to the method that
produces recombinants by the Red-recombination func-
tion of lambda phage. Short linear homologous DNA
strands (e.g. 20–70 bases) are required. Recombination
can occur between single-stranded or double-stranded
DNAs [34] by the exo, beta and gamma proteins of
lambda. Single-strand pairing is formed between a syn-
thetic oligonucleotide containing a mutation and single-
stranded chromosomal DNA arising from replication
fork. This requires beta, an annealing protein, and a 35-
nucleotide flanking homology on each end. To increase
the frequency of recombination, the oligonucleotide
should correspond to the lagging strand at the replication
fork and the direction of replication should be counter-
clockwise [35]. In this study, the deletion and substitution
fusion mutations were generated by single-strand pairing.
Appropriate oligonucleotides were created and synthe-
sized, then transformed into an E. coli strain containing
lambda prophage (Table 1). Chromosomal DNAs iso-
lated from the transformed cells were then amplified with
appropriate primers. Six candidates with DNAs expected
to encode RecBD fusion proteins were found for both
mutants by colony-screening, and two were isolated by
transduction (Figure 1b). They were named V2825 and
V2826.BMC Biochemistry 2008, 9:27 http://www.biomedcentral.com/1471-2091/9/27
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Haploid alleles of recB-recD fusion mutants have wild 
type phenotype
Purified transductants were subjected to the phage spot
test on LB plate with λ red-gam-χ+,  λ red-gam-χ0,  λ
red+gam+, T4, T4 gene 2- P1 and P2 phages (Table 2). The
sizes of plaques were evaluated [17] (Table 3): [1] λ red-
gam-χ0  formed small plaques, λ red-gam-χ+  formed
medium plaques, and λ red+gam+ formed large plaques.
a. The physical map of the thyA-argA region of the E. coli K-12 chromosome, and the nucleotide sequence of the recB-recD  overlap site where recBD fusion mutations were constructed Figure 1
a. The physical map of the thyA-argA region of the E. coli K-12 chromosome, and the nucleotide sequence of 
the recB-recD overlap site where recBD fusion mutations were constructed. The nucleotide A that overlaps the stop 
codon recB (TAA) and the start codon recD (atg) is shown in the square. recB nucleotides are depicted in capital letters while 
recD nucleotides are depicted in small letters in order to distinguish them. b. The sequence analysis results of the deletion 
(top) and substitution (bottom) fusion mutations after mutagenesis by recombineering.
5’ 
   
3’ 
5’---GGATGAGATCTTTGCCGGTATGACCCTGGAGGAGGCGTAatgaaattgcaaaagcaattactggaagctgtgg---3’ 
recD 
recB 
 thyA                recC                     ptr                    recB                    recD           argA
a
bBMC Biochemistry 2008, 9:27 http://www.biomedcentral.com/1471-2091/9/27
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In recBCD+ cells, λ red-gam-χ0 forms small plaques and λ
red-gam-χ+forms large ones, whereas in recBC mutants, χ0
and χ+ phages forms plaques of the same size. Our result
indicates that V2825 and V2826 have recombination-pro-
ficient phenotypes. [2] There were many plaques in the P1
spot. P1 lysogeny requires RecBCD recombination func-
tion, so fusion mutants are recombination-proficient [3].
λ red-gam-χ+produced larger plaques than λ red-gam-χ0;
this result suggests that there is a Chi hotspot activity. [4]
T4 formed plaques, but T4 lacking gene 2 protein did not.
Gene 2 protein protects T4 DNA ends from RecBCD exo-
nuclease degradation. In the absence of gene 2, T4 cannot
form plaques. This result indicates that the recB-recD
fusion mutants have exonuclease activity. [5] Many
plaques were found in the P2 spot. P2 phage growth
requires the exonuclease activity of RecBCD. Our result
suggests that fusion mutants have exonuclease activity.
recB-recD fusion mutants are recombination-proficient
The recombination proficiency of haploid alleles in the
recB-recD fusion mutants was measured in lambda vegeta-
tive crosses [16,17]. Table 4 shows the proficiency of
recombination by each mutant with recBCD+, recB null
mutant and the recD mutant. Both the deletion and sub-
stitution fusion mutants gave high recombination profi-
ciencies, similar to that of recBCD+ cells. recB null mutants
were found to be recombination-deficient and recD
mutants were recombination-proficient, as expected.
recB-recD fusion mutants have Chi activity
Chi activity was measured in hotspot crosses to determine
whether the fusion mutants interact with Chi [16,17]
(Table 4). The ratio of frequency of recombination in a
genetic interval with or without a Chi site gives Chi
hotspot activity. Both deletion and substitution fusion
mutants produced high Chi hotspot activities similar to
that of wild-type cells (approximately 6.0), indicating that
more exchange occurs in an interval with a Chi site than
that an interval without one. recBCD null mutants and
recD mutants produced no Chi hotspot activity (approxi-
mately 1.0).
recB-recD fusion mutants on plasmids have wild type 
phenotypes
The phenotypes of the recB-recD fusion mutants on plas-
mids were tested by spot tests [17] (Table 5). λ red-gam-
χ+produced larger plaques than λ red-gam-χ0. T4 formed
plaques, but T4 gene 2- did not. P1 and P2 produced
plaques. It was concluded that recB-recD fusion mutants
on plasmids are recombination-proficient and they have
Chi activity and exonuclease activity.
Table 1: Escherichia coli strains and plasmids used in this study
strains genotype source, ref,
HME63 Δ(argF-lac) U169 λ cI857 Δcro-bioA galK tyr 145 UAG mutS<>amp Court, 2003
AFT325 thyA argA21 recF143 hisG4 met rpsL31 galK2 xyl-5 λ- F- Amundsen,86
V2825 hisG4 met rpsL31 galK2 xyl-5 recBD2728 This study
V2826 hisG4 met rpsL31 galK2 xyl-5 recBD2729 This study
V2831 hisG4 met rpsL31 galK2 xyl-5 recBCD2731 (recBCDΔ) This study
V66 argA21 hisG4 recF143 met rpsL31 galK2 xyl-5 λ- F- Schultz,83
V67 RecB21::IS186 argA21 hisG4 recF143 met rpsL31 galK2 xyl-5 λ- F- Schultz,83
V222 argA::Tn10 argA21 hisG4 recF143 met rpsL31 galK2 xyl-5 λ- F- Amundsen,90
V1306 Thi-1 relA1 λ- (Hfr PO44) Schultz,83
594 Lac-3350 galK2 galT22 rpsL179 λ- F- Schultz,83
C600 Thr-1 leuB6 thi-1 lacY1 tonA21 supE44 rfbD1 λ- F- Schultz,83
plasmids
pBR322χ +F225 - Smith, 81
pDWS2 recBCD in pBR322 Ponticelli,85
pBD2728 2ntΔrecBD fusion in pBR322 This study
pBD2729 9nti recBD fusion in pBR322 This study
Table 2: Phage strains used in this study
Phage* Genotype Source, ref.
1081 λ sus J6 b1453 cI857 χ+ D123 F. and M. Stahl
1082 λ b1453 χ+ D123 sus R5 F. and M. Stahl
1083 λ sus J6 b1453 χ+ 76 cI857 F. and M. Stahl
1084 λ b1453 χ+ 76 sus R5 F. and M. Stahl
T4 T4B E.B. Goldberg
T4 gene2- T4 gene 2 amN51 E.B. Goldberg
P1 P1 vir-1 G.R. Smith
P2 P2 vir-1 R. Calender
801 λ+ G.R. Smith
*:Phages 1081–1084 obtained from G.R. Smith collection. b1453 is a 
deletion mutation of lambda removing int, red and part of gam. The 
χ+76 mutants are derived from a phage containing the b1453 
mutation.BMC Biochemistry 2008, 9:27 http://www.biomedcentral.com/1471-2091/9/27
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recB-recD fusion mutants on plasmids are recombination-
proficient
The recombination proficiency of recB-recD fusion
mutants on plasmids was tested by conjugational cross
[17] (Table 6). His+ recombinants in the plasmid deriva-
tives of recBD2728 and recBD2729 fusion mutants
increased to the wild-type value. These results show that
the fusion mutants are Rec+.
There are RecBD fusion polypeptides
We wanted to determine whether the construction of a
recB-recD fusion leads to an active RecBD fusion polypep-
tide. For this purpose, we performed native and denatur-
ing polyacrylamide gel electrophoresis of crude extracts
and blotted them. RecBD fusion polypeptides were
detected on SDS-PAGE probed with anti-RecB and anti-
RecD (Figures 2a, b), and RecC polypeptide was detected
when the gels were probed with anti-RecC (Figures 2c, d).
In the native gel, less heterotrimer was found in the two
fusion mutants than in purified RecBCD, but neither
intact RecB polypeptide nor RecBC was detected in cell
extracts of either fusion mutant (Figure 2d). Unexpect-
edly, a polypeptide with size similar to RecD was observed
(Figure 2b).
RecBDC fusion enzymes have ATP-dependent exonuclease 
activity
Because the fusion peptides were found on gels and they
were recombination-proficient, we wondered whether the
fusion mutants have enzyme activities. We first tested exo-
nuclease activity in them. RecBCD degrades linear DNA to
acid-soluble nucleotides by two activities, dsDNA and
ssDNA exonucleases, both of which are ATP-dependent.
We measured only ATP-dependent dsDNA exonuclease
activity in this work [36]; in both fusion mutants, it was
approximately half that in wild type (Table 7). This result
is consistent with the qualitative assays for exonuclease
activity with T4, T4 gene 2 and P2 (Table 5).
RecBDC fusion enzymes have DNA unwinding and Chi 
cutting activities
Since the fusion enzymes are recombination-proficient
and have Chi genetic activity, we wanted to demonstrate
DNA unwinding and Chi cutting activities, which are
measured together on linear dsDNA labeled with 32P at
the 5' end of a single strand containing a Chi site [24]. In
the presence of excess magnesium, wild-type RecBCD
binds to dsDNA ends and degrades the 3'-ended strand
until Chi site, so few if any ssDNA fragments are found.
After Chi, the enzyme cuts ssDNA a few nucleotides to the
3' side of Chi and forms a Chi fragment (Fig 3, lanes 5–8)
[see Additional file 1, lanes 3–5]. When we tested the
fusion enzymes for this activity, the deletion fusion
mutant enzyme had unwinding and exonuclease activi-
ties, so it did not produce a full-length ssDNA fragment
but could cut near Chi and form Chi fragments (Figure 3,
lanes 9–12). Similarly, the substitution fusion mutant
enzyme unwound dsDNA and degraded the 3'-end
strand, so it did not form an ssDNA fragment but formed
Chi fragments (Figure 3, lanes 13–16). These observations
are consistent with the phage test results.
recB-recD fusion mutants are resistant to DNA damaging 
agents
The viability of the fusion mutant cells was tested by their
sensitivity to DNA damaging agents [37,38]. Deletion and
substitution fusion mutants were just as resistant to UV
radiation as the recBCD wild type strain when compared
to pBR322 (Figure 4). Both fusion mutants showed simi-
lar ability to the recBCD wild type strain in reducing DNA
damage induced by Mitomycin C (Figure 5), but plasmids
were sensitive. These data show that recB-recD fusions do
not inhibit DNA repair.
Discussion
We set out to characterize the regulatory function of RecD.
To our knowledge, this is the first study involving the gen-
Table 3: Phage spot test results in haploid alleles of recBD fusion mutants
rec alleles* λ phage T4 phage P1 phage P2 phage
λ red-
gam-χ0
λ red-
gam-χ+
λ red+ 
gam+
gene 2
pr(-)
gene 2
pr(+)
recBCD small medium large + - + +
recBD2728 small medium large + - + +
recBD2729 small medium large + - + +
* Strains are transformants of V2831 (ΔrecBCD2731) with the indicated rec alleles on the chromosome.
Table 4: Lambda hotspot cross results in haploid alleles of recBD 
fusion mutants
rec alleles* λ Recombination Frequency (%J+R+)# Chi Activity#
recBCD 7.48 ± 1.86 6.03 ± 0.78
recB21 0.13 ± 0.08 1.06 ± 0.09
recD1013 6.33 ± 1.24 1.23 ± 0.16
recBD2728 5.82 ± 0.83 5.20 ± 0.28
recBD2729 7.5 ± 1.25 6.69 ± 0.88
* Strains are transformants of V2831 (ΔrecBCD2731) with the 
indicated rec alleles on the chromosome except recB21 and recD1013 
which are derivatives of V66 (rpsL31).BMC Biochemistry 2008, 9:27 http://www.biomedcentral.com/1471-2091/9/27
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eration of genetic fusions between two RecBCD subunits.
We observed that the fusion enzymes have wild type phe-
notypes. Below, we discuss possible inferences from our
results.
Fusion enzymes resemble wild type
The phenotypes of the fusion enzymes were demonstrated
by genetic and enzymatic assays (Table 8). The deletion
fusion enzyme is recombination proficient and resistant
to DNA damaging agents (Table 3, 4, 5, 6, Figures 4, 5). In
contrast to RecBC, this mutant enzyme has nuclease and
Chi genetic activities (Table 7, Figure 3). It can unwind
dsDNA as wild type enzyme does and recognizes the Chi
sequence because it forms Chi fragments (Figure 4). Sim-
ilarly, we found that the substitution fusion enzyme is
recombination proficient and resistant to DNA damaging
agents (Table 3, 4, 5, 6, Figures 4, 5). This mutant enzyme
has Chi activity, nuclease and helicase activities, and also
recognizes Chi (Table 7, Figure 3). Our findings indicate
that both fusion enzymes can bind to dsDNA ends and
unwind double strands. During unwinding they can rec-
ognize the Chi sequence and form a 3' overhang. After
interaction with Chi, wild type RecBCD enzyme loads
RecA protein on to the free 3' end [24], which allows pair-
ing and strand exchange with homologues [15], so this
activity is required for homologous recombination [33].
We did not measure RecA loading activity in this study,
but the genetic measure of recombination proficiency and
enzymatic measure of Chi recognition [32] afford evi-
dence for such activity.
Fusion enzymes are active
In our mutations we removed the stop codon of recB, so
translation continued to the end of the recD coding
sequence and produced a RecBD fusion heterodimer,
which might affect the folding of the enzyme and conse-
quently its functions. Folding is a rapid process initiated
by local elements that assemble to yield the final native
fold [39,40]. Our protein analysis indicated not only the
presence of RecBD fusion polypeptide, as we expected
(Figures 2a–c), but also the absence of intact RecB mono-
mer and RecBC dimer (Figure 2d). This result is the most
important evidence for a RecBD fusion heterodimer. An
intact RecC that we found is essential for assembly and
association into holoenzyme. However, we observed that
the amount of heterotrimer was lower than in wild type.
One possible explanation is that the assembly of the
fusion protein to form the heterotrimer was affected
because an oligomeric protein is formed by consecutive
folding and association of the constituent polypeptides. A
more significant finding than the reduction of heterot-
rimer level is RecD with wild type length. This indicates
that the RecD polypeptide is expressed by its minor pro-
moter, which may affect the assembly process. In E. coli,
recB and recD form an operon with two promoters; the
major promoter is external and directs the transcription of
both genes, whereas the minor one is internal and appears
to direct the transcription of recD. A similar promoter
composition is found in other E. coli operons such as
glnALG and rpsU-dnaG-rpoD; the minor promoter allows
downstream genes to be transcribed under certain condi-
tions [6]. However, it is not yet clear when the weaker pro-
moter for recD  governs, so we did not take it into
consideration at the outset. Nevertheless, wild type length
RecD could bind to Rec(BD fusion)-RecC assembly and
could make Rec(BD fusion)-RecC-RecD enzyme that
might be responsible for the functionality (Figure 6).
During our study the three-dimensional structure of
RecBCD was discovered. It was found that the distance
Table 5: Phage spot test results of recBD fusion mutants on plasmid
rec alleles* λ phage T4 phage P1 phage P2 phage
λ red-
gam-χ0
λ red-
gam-χ+
λ red+ 
gam+
gene 2
pr(-)
gene 2
pr(+)
+ small medium Large + - + +
recBD2728 small medium large + - + +
recBD2729 small medium large + - + +
- small small large + + - -
*Strains are transformants of strain V2831(ΔrecBCD2731) with derivatives of plasmid pBR322 containing the indicated rec alleles. "-" means 
pBR322.
Table 6: Hfr conjugation results of recBD fusion mutants on 
plasmid
rec alleles* Hfr conjugation (%His + [Str+])#
+ 1.13 ± 0.057
recBD2728 1.26 ± 0.17
recBD2729 1.31 ± 0.13
- 0.00
*: Strains are transformants of strain V2831(ΔrecBCD2731) with. the 
indicated rec alleles on derivatives of plasmid pBR322. "-" contains 
pBR322.
#: Results are the mean ± SEM from 2 and 3 experiments.BMC Biochemistry 2008, 9:27 http://www.biomedcentral.com/1471-2091/9/27
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between 1174 of RecB polypeptide and 2 of RecD
polypeptide is about 60.8 Å (Wigley and colleagues, per-
sonal communication) [see Additional file 2], which is
longer than was thought. This distance corresponds to
about 17 amino acids. However, in our study, three
amino acids were substituted between 1180 of RecB and 1
of RecD, so it corresponds to total 10 amino acids (about
35 Å). Therefore at least seven more amino acids may be
required to fuse recB and recD. Furthermore, this long dis-
tance between C-terminal of RecB and N-terminal of RecD
may cause a functional enzyme which may be assembled
by Rec(BD fusion)-RecC-Rec(BD fusion), in which RecB
and RecD come from two different polypeptides.
Genetic studies showed that there is little or no Chi
hotspot activity in frameshift or single amino acid muta-
RecBD fusion polypeptides are shown in lanes 10–15 of part a and in lanes 8–13 of part b Figure 2
RecBD fusion polypeptides are shown in lanes 10–15 of part a and in lanes 8–13 of part b. Intact RecC polypeptides 
are shown in lanes 10–15 of part c and in lanes 4–9 of part d. RecBD fusion mutants do not assemble into the heterotrimer (in 
lanes 4–9 of part d). Extracts were from late log phase cultures of V2831 containing derivatives of plasmids pDWS2 (recBCD+), 
pBD2728 and pBD2729. Fusion polypeptides in cell extracts were separated on denaturing (3–8% Tris acetate or 4–12% Bis-
Tris buffer) and native (5% in 2 mM EDTA, 50 mM MOPS pH 7.0) polyacrylamide gels. Proteins were transferred to PVDF 
membrane and probed with mouse monoclonal antibodies specific for RecB, RecC and RecD, which were captured and visual-
ized with horseradish peroxidase-linked antimouse IgG.
a b
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tions of RecC(recC*, recC343 respectively) [17-19]. There-
fore it was proposed that hotspot Chi is recognized by
RecC as the 3' single strand DNA during unwinding [5,18-
20]. It was suggested that this recognition initiates a sig-
nal, which causes a change in RecD polypeptide to form
3'overhang to the left of Chi for RecA loading [20]. Based
on our observations, it can be suggested that this signaling
in both RecBDC fusion enzymes would retain in response
to Chi.
The results presented here suggest that RecBD fusion
enzymes have wild type phenotype and fully active. How-
ever, considering the distance between C-terminal of RecB
and N-terminal of RecD in the three-dimensional struc-
ture, and the presence of wild type-length RecD, unusual
subunit associations such as Rec(BD fusion)-RecC-RecD
and Rec(BD fusion)-RecC-Rec(BD fusion) may be formed
and may be responsible for the activity. To rule out this
possibility, purification of those discrete molecules and
then their extensive biochemical assays are required. For
this purpose, purification methods, SDS-PAGE analysis
and MALDI-TOF MS can be performed [41,42].
Conclusion
recB-recD genetic fusion in E. coli demonstrates that
RecBDC fusion enzymes are recombination proficient
and active as well as wild type, so we infer that three-
dimensional structure of fusion proteins does not change.
The reduced heterotrimer formation may arise from the
failure of RecD assembly process. However, wild type
length RecD requires a purification to eliminate subunit
associations that might be responsible for the enzyme
activities.
Methods
Bacteria, phage and plasmids
Bacterial strains and plasmids are shown in Table 1, and
phages are listed in Table 2 with their genotypes and
sources. recBCD+ means recB+, recC+ and recD+. Rec+ indi-
cates a strain with recBCD+ and recA+.
Table 7: ATP-dependent dsDNA exonuclease activity results of 
recBD fusion mutants
rec alleles* dsDNA exonuclease
+ 333 ± 37.47
recBD2728 118.60 ± 16.67
recBD2729 126.35 ± 22.30
-1 8  ±  2 . 4 4
*: Strains are transformants of strain V2831 (recBCDΔ) with 
derivatives of plasmid pBR322 containing the indicated rec alleles. "-" 
means pBR322
#: Results are the mean ± SEM from 3 experiments.
RecBD fusion enzymes unwind dsDNA and make a cut after  Chi Figure 3
RecBD fusion enzymes unwind dsDNA and make a 
cut after Chi. DNA unwinding and Chi cutting activities of 
the fusion enzymes were measured using pBR322 χ + DNA 
substrate labeled with 5'-32P. DNA substrates (4.5 nM) were 
incubated with crude extracts at 3.5 mM magnesium, moni-
tored on 1% agarose gels and analyzed by autoradiography.
5’* 
3’ 
Chi 
3
’ 
5
dsDNA 
ssDNA 
Chi 
  1    2    3    4      5     6     7    8     9  10  11  12    13  14 15  16 
Enzyme         pBR322              pDWS2           pBD2728            pBD2729 
7.5 2.5 0.8 0.28     7.5  2.5  0.8 0.28  7.5 2.5  0.8  0.28   7.5 2.5 0.8 0.28 μg 
Substrate               χ+
The survival of recBD fusion strains after exposure to UV is  similar to wild type Figure 4
The survival of recBD fusion strains after exposure to 
UV is similar to wild type. Strains are transformants of 
V2831 containing recBD fusion alleles on a plasmid. Cultures 
were grown to mid log phase at 37°C in LB broth, exposed 
to UV radiation for 0, 5, 10 and 15 s, and plated on LB agar. 
Survival is defined as the fraction of initial colony forming 
units surviving after UV exposure.
0”   5”   10”  15”   
pDWS2 
pBD2728 
pBD2729 
pBR322 BMC Biochemistry 2008, 9:27 http://www.biomedcentral.com/1471-2091/9/27
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Media
Tryptone broth, minimal medium (OMBG), phage sus-
pension medium (SM) and LB (Lurial bertani) agar have
been described [17]. BBL agar contains trypticase (BBL-
microbiology systems, Maryland); BBL-YE contains 0.1%
yeast extract. Terrific broth contains yeast extract, trypti-
case and glycerol.
Materials
Oligonucleotides were purchased from Integrated DNA
Technologies Inc (IDT, Coralville, IL, USA), the chromo-
somal DNA isolation kit from Promega (Madison, WI,
USA), the protein assay kit and non-fat dried milk from
BioRad (USA), electrophoresis equipment for DNA from
Ellard Instrumentation (USA) and for protein from Bio-
Rad and Invitrogen (USA); and chemicals were purchased
from Sigma Chemical Company (USA) and Fisher Scien-
tific (USA).
Mutagenesis
For recombineering, two oligonucleotides were designed.
The first, containing a TA deletion at the recB stop codon,
5'-TACTCTACAAACGGCCATACTGGGACCTCCTCCGCT
ACTTTAACGTTTTCGTTAATGACCTTCGACACCT-3', was
used for the deletion mutation. The second, containing an
aac-ggt-aac substitution at the overlap site, 5'-CCTACTCT-
ACAAACGGCCATACTGGGACCTCCTCCGCTT GCCATT-
GACT TTAACGTTTTCGTTAATGACCTTCGACACC-3', was
used for the substitution mutation. Oligonucleotides cor-
responded to the lagging strand at the replication fork and
contained a 35 nucleotide flanking homology on each
side [34,35]. Recombineering was performed on an E. coli
strain (HME63) lacking the mismatch repair system but
containing lambda prophage. A fresh culture of HME63 at
32°C was divided into two flasks. Half the culture was not
induced but was kept for future use. The other half was
induced by incubating at 42°C for 15 min, then on ice for
15 min. The culture was centrifuged at 4600 g and the pel-
let was dispersed in 1 ml cold water; 30 ml cold water was
added and the suspension was centrifuged. The pellet was
again dispersed in 1 ml cold water and centrifuged, and
the pellet was dispersed in 200 μl cold water. Forty-five μl
of induced cells was transferred into three electroporation
cuvettes. Fifteen pmol of fusion oligo and 15 pmol of gal
oligo were added to the second and third cuvettes, respec-
tively. Forty-five μl of uninduced cells was transferred to
two electroporation cuvettes. Fifteen pmol of gal oligo
was added to the second cuvette. Electroporation was per-
Both RecBD fusion mutants are resistant to Mitomycin C.  Strains are transformants of V2831 containing rec alleles on a  plasmid Figure 5
Both RecBD fusion mutants are resistant to Mitomy-
cin C. Strains are transformants of V2831 containing rec 
alleles on a plasmid. Cultures were grown to mid log phase in 
LB broth, and plated on LB agar plates with or without Mito-
mycin C. Survival was determined by colony formation. a, b, 
c and d represent pBD2729, pDWS2, pBD2728 and pBR322, 
respectively.
         a               b
            c            d
   a              b
     c           d
  a            b
    c          d
         a             b
      c           d
0 μg/ml 0.06  μg/ml  
0.25 μg/ml  0.12 μg/ml 
Table 8: Summary of recBD fusion mutant phenotypes
rec alleles* DNA damaging agents Recombination Enzyme
Activities
Mtc C UV %J+R+ Hfr
conjugation
Chi
activity
dsDNA exonuclease DNA unwinding Chi
cutting
+R R + + + + + +
recBD2728 R R + + + + + +
recBD2729 R R + + + + + +
-S S - - - - - -
*: Strains are tranformants of V2831(recBCD2731) with the indicated rec alleles on derivatives of plasmid pBR322. "-" contains pBR322.
(R, resistant to agent; S, sensitive to agent)BMC Biochemistry 2008, 9:27 http://www.biomedcentral.com/1471-2091/9/27
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formed at 1.8 kV. LB (1 ml) was added to each cuvette. The
cells were diluted with SM and spread on LB plates.
Mutant detection
A large chromosomal fragment (1.7 kb) containing fusion
mutations was amplified. Two primers were used; the for-
ward was relative to 1046 bp to the mutation site, and the
reverse was relative to 656 bp (IDT). Transformed cells
were grown overnight at 42°C. Fifty patch-grid plates were
prepared from these fresh colonies. The cells were lysed at
96°C for 8 min. The chromosomal DNA was amplified in
a reaction mixture containing 0.2 μM of each primer, 1.5
mM MgCl2, 0.2 mM dNTPs and 1 U Taq polymerase (Inv-
itrogen, San Diago). The conditions of amplification were
as follows: 94°C for 15 s, 55°C for 30 s, and 72°C for 2
min (30 cycles). PCR products were digested by BsaXI for
Model for the structures and functions of RecBDC fusion enzyme Figure 6
Model for the structures and functions of RecBDC fusion enzyme.a. The construction of RecBD fusion enzyme. b. 
RecBD fusion enzyme may assemble with RecC and may form an active fusion heterotrimer, or wild type length RecD may 
assemble to fusion heterotrimer yielding unusual subunit associations.
a
b
Genetic  
fusion  B 
C 
D
D
BD 
C 
RecBCD   RecBD fusion  
enzyme 
3’ 
5’ 
3’ 
5’ 
Chi  B 
C 
D 
RecBCD   dsDNA 
Chi 
dsDNA  C 
D
BD
RecBD fusion  
enzyme 
Chi 
dsDNA 
3’ 
5’ 
D
BD 
C
Genetic  
fusion BMC Biochemistry 2008, 9:27 http://www.biomedcentral.com/1471-2091/9/27
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the deletion mutation, and by NlaIII for the substitution
mutation (New England BioLabs). As a result, approxi-
mately 1750 colonies were screened by colony PCR. A
total of 5 candidates were detected for the deletion muta-
tion and 1 candidate for the substitution mutation. Those
candidates were purified and sequenced (Big Dye Cycle
Sequencing Protocol, PE Biosystems).
Mutant isolation
Mutagenesis was generated in an E. coli strain
(thy+arg+recBCD+) containing lambda prophage. To
remove lambda phage, the mutants were transferred to
another strain (thy-arg-Δ recBCD) by P1 transduction and
then  thy+arg+recombinants were selected. P1-mediated
transduction was performed by the plate stock method
[17]. A cell culture grown at 32°C overnight was mixed
with P1 phage grown on the donor strain at an MOI of 0.5
and incubated at 37°C for adsorption. The cells were
grown overnight, harvested and centrifuged. The superna-
tant was the P1 phage stock containing the mutant strain.
Phages were mixed with fresh E. coli cells (thy-arg-Δ
recBCD) at 37°C for adsorption. Sodium citrate was
added to stop phage adsorption. Transductants were
selected on minimal medium containing histidine and
methionine, then purified. The phenotypes of the mutant
candidates were tested by a phage sensitivity test on LB
plate [17]. Fresh cultures of fusion mutants in TB were
mixed with BBL-top agar, and poured on to BBL agar
plates. Seven phages (104 pfu/ml) were placed on the
spots. Recombination frequency and Chi genetic activity
were tested by λ red-gam-χ+, λ red-gam-χ0, λ red+gam+ and
P1 phages: λ red-gam-χ+and λ red-gam-χ0 produce plaques
in Rec+cells. The sizes of the plaques in those spots reflect
Chi activity. P1 needs Rec+ cells to grow. Exonuclease
activity was tested by T4, T4 gene 2- and P2 phages. Gene 2
protein binds to the ends of T4 DNA and protects T4 DNA
from the exonuclease activity of RecBCD after injection
into the cell. P2 requires RecBCD exonuclease activity to
grow. Recombination frequency and Chi genetic activity
were assayed quantitatively by hotspot crosses as
described by Schultz [17]. First, the stocks of lambda
phages 1081, 1082, 1083 and 1084 were prepared. Cross
1 was made between parents 1081(c+) and 1082 (cI857),
and Cross2 was made between parents 1083(c+) and 1084
(cI857). A fusion mutant culture (100 μl) was infected
with 5 phages per cell. The mixture was incubated at 37°C
for phage adsorption. The total phage count was titered
on a (sup-) strain on BBL whereas the recombinant phage
count was titered on a (sup+) strain on BBL-YE plates.
Recombination frequency (%J+R+) was determined by the
percentage ratio of recombinant phage count to total
phage count on the same interval for two crosses. Chi
activity was determined by counting the turbid plaques on
a (sup-) strain on BBL plates and clear plaques on a (sup+)
strain on BBL-YE plates. The square root of ratio of the tur-
bid plaques to clear plaques in Cross 1 to Cross 2 gives the
Chi activity.
Cloning of fusion mutants
A 18.3 kb BamH1 fragment containing either wild type
recBCD or recB-recD fusion mutants was ligated into the
BamHI site of pBR322 by T4 DNA ligase (New England
BioLabs), and transformed into V2831 thy--arg- cells to
select  thy+-arg+ cells. Transformants were confirmed by
sequencing. The orientation of the plasmid was tested by
Pst1 digestion.
Preparation of cell-free extracts and protein assays
Crude cell extracts were prepared by a modified Eichler-
Lehman method [36]. Isolated colonies of purified trans-
formants were grown in terrific broth. Fresh culture was
grown to OD650 >2.0, centrifuged and washed. The pellet
was resuspended in 50 mM Tris pH 7.5, 10% sucrose and
1 mM EDTA. Aliquots were stored at -70°C in liquid
nitrogen. Cells were thawed, their volume was measured,
and 100 mM PMSF, 50 mM DTT and 500 mM EDTA were
added to reach the final concentration. Lysozyme (10 mg/
ml) was added to the mixture and incubated on ice for 5
min. NaCl (5 M) was added, incubated on ice and centri-
fuged for 30 min. The supernatant was removed and the
protein concentrations of the extracts were determined
(BioRad). Native gels (5% polyacrylamide, 37.5:1 acryla-
mide:bis in 50 mM MOPS-KOH, pH 7.0) and SDS gels
(3–8% of polyacrylamide in 50 mM Tris-acetate buffer,
pH 8.25, or 4–12% of polyacrylamide in 1.25 M Bis-Tris
buffer, pH 6.5–6,8) were poured in gel cassettes [20]. The
gels were prerun for 1 h, and samples were mixed with
loading solution and run at 100 V overnight at 4°C. Pro-
teins were transferred to PVDF membranes (Immobilon-
P, Millipore) and probed with mouse monoclonal anti-
bodies specific for RecB, RecD or RecC. The antibodies
were visualized with horseradish peroxidase-linked anti-
mouse IgG and a Phototope-HRP detection kit (New Eng-
land Biolabs).
Hfr conjugation
The recombination frequency of the fusion mutants on
plasmids was tested by Hfr crosses. The donor V1306
strain (his+ rpsL+) was mixed with the recipient recB-recD
fusion mutants (hisG4  rpsL31) as described by Schultz
[17]. The ratio of donor to recipient was 1:10. Mating cells
were incubated in a 37°C water-bath for 8 min. Diluted
mating cells were grown for 20 min and were plated on
selective minimal medium (OMBG) containing methio-
nine and streptomycin to select His+ strR recombinants.
Diluted recipient cells (10-5 dilutions) were plated on
LB+amp. The number of His exconjugants per donor cor-
rected by viability of the recipient strains is called the
recombination frequency.BMC Biochemistry 2008, 9:27 http://www.biomedcentral.com/1471-2091/9/27
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Cell viability assays
The viability of recB-recD fusion mutant cells on plasmids
was determined by two qualitative assays. In both, small
colony formation means low cell viability, and no growth
means sensitivity to that agent. In the UV sensitivity assay,
fresh overnight cultures were grown to mid-log phase and
exposed to UV (10 erg/m2/s) for 5–20 s [37]. Cells were
incubated at 37°C in the dark overnight, and colony
growth was observed on the following day. In the Mito-
mycin C(MC) sensitivity assay [38], plasmid alleles of the
fusion mutants were streaked on LB agar plates containing
0, 0.06, 0.12, 0.25 or 0.50 μg Mitomycin C, incubated at
37°C overnight, and checked for colony growth.
Enzyme activity assays
DNA unwinding, Chi cutting and dsDNA exonuclease
activities were determined in crude extracts of the fusion
mutants. ATP-dependent dsDNA exonuclease activity was
measured according to Eichler-Lehman [36]. Crude
extracts were mixed with [3H] T7DNA, 25 μM ATP, BSA,
500 mM Tris HCl pH 8.5, 100 mM MgCl2 and 10 mM
DDT and incubated at 37°C for 20 min. Carrier DNA (0.2
mg/ml) and 5% TCA were added and the mixture was
incubated on ice and centrifuged. The supernatant, con-
taining acid-soluble nucleotides, was counted using a
Beckman Coulter Scintillation Counter. One unit of
enzyme was defined an amount that solubilizes 5 nmol of
dsDNA at 37°C in 20 min.
Chi cutting and DNA unwinding activities were measured
together [24]. The substrate, plasmid DNA χ+F, was made
linear with HindIII (New England BioLabs), incubated
with shrimp alkaline phosphatase (SAP) (Invitrogen) at
37°C for 30 min, and labeled with γ32P at the 5'ends by
T4 polynucleotide kinase (Invitrogen) at 25°C for 30 min.
Free nucleotides were removed with an SR-200 mini col-
umn. DNA substrate (4.5 nM) was mixed with the indi-
cated amount of cell-free extract in 20 mM MOPS pH 7.5,
3.5 mM MgCl2, 5 mM ATP, 1 mM DTT, and 1.6 μM SSB
(Promega). After 2 min, ATP-γS and M13 DNA were
added. Reaction products were separated on a 1% agarose
gel and analyzed by autoradiography.
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